Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Masanneck

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|August 4, 2025
Analyzing Access to Child and Adolescent Psychiatric Care Institutes in Germany Based on Driving TimeLars Masanneck, Jonathan Repple, Sven G Meuth, et al.
International Journal of Molecular Sciences|December 9, 2020
The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple SclerosisLars Masanneck, Susann Eichler, Anna Vogelsang, et al.
Frontiers in Neurology|March 6, 2026
Mind the gap: a German case study on the discrepancy between geographic accessibility and real-world utilization of botulinum toxin therapyTristan Koelsche, Robin Jansen, Lars Masanneck, et al.
Neurological Research and Practice|August 23, 2023
Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept studyLars Masanneck, Jan Voth, Niklas Huntemann, et al.
Digital Health|February 10, 2023
Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in GermanyLars Masanneck, Saskia Räuber, Christina B Schroeter, et al.
Frontiers in Neurology|October 18, 2024
Myasthenia Gravis: utilising cross-platform quantitative content analysis to uncover and validate unmet needsDavid Legg, Andreas Meisel, Maike Stein, et al.
The Lancet Regional Health. Europe|February 16, 2026
Direct stroke unit access versus a hub-and-spoke model with telemedicine-assisted CT in Germany: a cross-sectional geospatial analysisLars Masanneck, Marius Vach, Julian Caspers, et al.
Fortschritte Der Neurologie-Psychiatrie|July 13, 2026
[Neurofilament light chain as a tool for assessing disease activity and treatment response in Multiple Sclerosis]Hernan Inojosa, Katja Akgün, Lars Masanneck, et al.
Journal of the Peripheral Nervous System : JPNS|November 19, 2025
Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating PolyneuropathyJan Voth, Charlotte von Gall, Noëmi Gmahl, et al.
Journal of Medical Internet Research|June 14, 2024
Triage Performance Across Large Language Models, ChatGPT, and Untrained Doctors in Emergency Medicine: Comparative StudyLars Masanneck, Linea Schmidt, Antonia Seifert, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|August 4, 2025
Analyzing Access to Child and Adolescent Psychiatric Care Institutes in Germany Based on Driving TimeLars Masanneck, Jonathan Repple, Sven G Meuth, et al.
International Journal of Molecular Sciences|December 9, 2020
The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple SclerosisLars Masanneck, Susann Eichler, Anna Vogelsang, et al.
Frontiers in Neurology|March 6, 2026
Mind the gap: a German case study on the discrepancy between geographic accessibility and real-world utilization of botulinum toxin therapyTristan Koelsche, Robin Jansen, Lars Masanneck, et al.
Neurological Research and Practice|August 23, 2023
Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept studyLars Masanneck, Jan Voth, Niklas Huntemann, et al.
Digital Health|February 10, 2023
Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in GermanyLars Masanneck, Saskia Räuber, Christina B Schroeter, et al.
Frontiers in Neurology|October 18, 2024
Myasthenia Gravis: utilising cross-platform quantitative content analysis to uncover and validate unmet needsDavid Legg, Andreas Meisel, Maike Stein, et al.
The Lancet Regional Health. Europe|February 16, 2026
Direct stroke unit access versus a hub-and-spoke model with telemedicine-assisted CT in Germany: a cross-sectional geospatial analysisLars Masanneck, Marius Vach, Julian Caspers, et al.
Fortschritte Der Neurologie-Psychiatrie|July 13, 2026
[Neurofilament light chain as a tool for assessing disease activity and treatment response in Multiple Sclerosis]Hernan Inojosa, Katja Akgün, Lars Masanneck, et al.
Journal of the Peripheral Nervous System : JPNS|November 19, 2025
Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating PolyneuropathyJan Voth, Charlotte von Gall, Noëmi Gmahl, et al.
Journal of Medical Internet Research|June 14, 2024
Triage Performance Across Large Language Models, ChatGPT, and Untrained Doctors in Emergency Medicine: Comparative StudyLars Masanneck, Linea Schmidt, Antonia Seifert, et al.
Pageof 4